Please login to the form below

Not currently logged in
Email:
Password:

Organ allocation system to be reviewed

The rules governing organ transplants for NHS patients and non-UK EU residents are to be reviewed

The rules governing organ transplants for NHS patients and non-UK EU residents are to be reviewed.

Health Secretary Alan Johnson announced the review, which aims to ensure public confidence in the fairness of the system that sees many organs from deceased UK donors transplanted into non-UK resident EU nationals each year.

"We are aware that some people resident in other countries within the European Union needing transplants are being referred to the UK. This had led to accusations of priority being given to non-UK patients. We want to optimise the availability of organs for transplant for NHS patients and ensure public confidence in the fairness and transparency of the organ allocation system in the UK," said Johnson.

As well as reassuring the public about the integrity of the UK transplant programme, the review will enable individual transplant centres to review their policies ensuring the needs of UK patients are met within the framework of European law.

Chair of the former Organ Donation Taskforce, Elisabeth Buggins will lead the review. Commenting on her role, she said: "I recognise that this is a complex and sensitive area. It is important to be able to build the confidence of the public in the integrity of the systems that determine how precious donated organs are allocated to individual patients, and to provide clear guidance to the transplant community."

11th March 2009

From: Healthcare

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics